The good, the bad, the ugly and the fabulous
Dr Jane Munro, Head of Rheumatology at RCH, will present 3 different programs of quality of care improvements undertaken over the past decade at RCH
Video
Ethical issues in caring for asylum seeker children
David went to Nauru in December to see children referred to him. He will present a case related to this visit and will discuss what are our ethical responsibilities to asylum seekers and the role of advocacy
Understanding brain trauma better in the 21st century
Brain trauma is a common reason for death in children and young adults, a major cause of long-term disability, and huge economic costs from rehabilitation, care and loss of productivity. Understanding the mechanisms of injury and having improved treatment strategies may mitigate some of the burden of neuro-trauma. This talk will cover international efforts to better understand brain trauma. There are many current inadequacies in our knowledge of this condition. Dr Michael Bell and his team at the University of Pittsburg are heading several research projects to answer these issues.
Mission Accomplished? What novel gene discovery teaches us about leukodystrophies
Leukodystrophies remain a diagnostic challenge for practitioners and families. Next generation sequencing (NGS) offers exciting opportunities to expand our understanding of disease phenotypes and to explore pathophysiologic mechanisms, based on the molecular cause of abnormalities in central nervous system white matter. The diagnostic odyssey and its implications are discussed, from the perspective of an Australian family. Additionally, an update is provided on the contributions of NGS to the description of novel leukodystrophies and their treatments in this ever expanding field.
Cerebral palsy – a changing landscape 2015 and beyond
The WHO’s International Classification of Functioning (ICF) was published in 2001. Advocates in the field of developmental disability have been promoting its use as an integrated and strengths-based approach to our thinking, actions, and research. Building on the ICF framework, colleagues at CanChild Centre in Canada published a tongue-in-cheek paper entitled “The F-words in Childhood Disability: I swear this is how we should think”.
Implementing Genomics into Clinical Care at Melbourne Children’s
Genomic technologies have the potential to transform how we deliver healthcare. Genomic medicine promises better patient outcomes and a more efficient health system through rapid diagnosis, early intervention, prevention and targeted therapies. However, there are significant hurdles that need to be overcome to implement genomics into routine clinical practice.
The elephant in the room – type 1 diabetes, adverse brain development and metabolic control
Arguably the pre-eminent developmental task of childhood is to grow a good brain. Glucose is the primary metabolic fuel for the brain- peaking at 140-170 grams per day at around 5 years of age with a constant supply critical for normal cerebral metabolism. Thus it is not surprising that developing brains in early childhood are more susceptible to metabolic insult, particularly those resulting from perturbations in blood glucose levels. Type 1 diabetes (T1DM) is one of the most common chronic diseases of childhood and the condition most likely to cause the greatest fluctuations in blood glucose
Learning from the past to shape the future: The Centre for Community Child Health celebrates 21 years
For over 21 years, the Centre for Community Child Health (CCCH) has been working with children, families and communities to promote healthy development and equity of outcomes. The Centre was founded in 1994 by Professor Frank Oberklaid OAM, and has grown into a 100-strong team – recognised nationally and internationally for leadership in child health and development.
Ethical Leadership Without Easy Answers
There is no easy formula for ethical leadership in a world where systematic ethical analysis is rare and cognitive processes work against us. We will explore how we can meet these challenges and lead more ethically
The new frontiers of medical engineering
The development of new medical technology requires the collaboration of engineering, IT, medicine, science and industrial design. The Monash Institute of Medical Engineering (MIME) fosters the development of new medical technologies across the whole spectrum of medical science. A prime example of this is the bionic vision device which has been developed over the last five years. This is a ‘brain-machine’ device to restore visual function to blind individuals. I will be presenting this research project but also some of the other exciting areas of medical engineering including the development of replacement body parts such as the ear and the trachea using bio-printing techniques and ‘laboratory on-a-chip’ technology. There is great scope for medical engineering in paediatrics.